by Anusuya Lahiri | Jul 13, 2026 | General
NVIDIA Corp. (NASDAQ:NVDA) stock is down more than 1% in Monday’s premarket session as investors trimmed exposure to high-growth technology stocks. Nasdaq futures fell 1.12%, while S&P 500 futures lost 0.39%, weighing on semiconductor names. Investors turned more...
by Rishabh Mishra | Jul 13, 2026 | General
CNBC’s Jim Cramer argues that AMC Entertainment Holdings Inc. (NYSE:AMC) was doomed as a long-term investment because a debt-laden balance sheet severely restricted its ability to survive economic pressures, giving the movie theater chain an expiration date despite...
by Kaustubh Bagalkote | Jul 13, 2026 | General
Sandisk Corporation (NASDAQ:SNDK) stock was down more than 5% in Monday’s premarket session as investors reduced exposure to growth stocks amid a broader risk-off market. Nasdaq futures fell 1.04%, while S&P 500 futures slipped 0.36%. Geopolitical Tensions Spark...
by Kaustubh Bagalkote | Jul 13, 2026 | General
Earnings season kicks into high gear next week, with a slate of heavyweight companies set to report quarterly results between July 12 and July 18. As investors look for fresh insight into corporate earnings, guidance and the broader economic backdrop, options traders...
by Avi Kapoor | Jul 13, 2026 | General
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Keefe, Bruyette & Woods analyst Ryan Tomasello downgraded...
by Dylan Berman | Jul 13, 2026 | General
Merck & Co. Inc. (NYSE:MRK) shares are in focus Monday after a wave of analyst activity capped by a new FDA approval for its cancer drug Keytruda. Merck stock is trading near recent highs. What’s the outlook for MRK shares? Analyst Consensus and Recent Actions The...
Recent Comments